Xybaid 500 mg tvrde kapsule
| Name | Xybaid 500 mg tvrde kapsule |
|---|---|
| Marketing Authorisation Number | HR-H-183510973 |
| Active Substance | hidroksikarbamid |
| Composition | jedna kapsula sadrži 500 mg hidroksikarbamida |
| Pharmaceutical Form | kapsula, tvrda |
| Manufacturer | Pharmadox Healthcare Limited, Paola, Malta |
| Marketing Authorisation Holder | Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, Hrvatska |
| Marketing Authorisation Date | 18.06.2020 |
| MA Period of Validity | 18.06.2025 |
| Classification Number | UP/I-530-09/19-01/121 |
| Registration Number | 381-12-01/38-20-16 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01XX05 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
